Abstract

No AccessJournal of UrologyAdult Urology1 May 2021Editorial CommentThis article comments on the following:Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial Jiun-Ruey Hu, and Paula Hurley Jiun-Ruey HuJiun-Ruey Hu Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee More articles by this author , and Paula HurleyPaula Hurley Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001531.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, 205(5), pp. 1377–1378 © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyDec 22, 2020, 12:00:00 AMOther and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial Volume 205Issue 5May 2021Page: 1377-1378 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jiun-Ruey Hu Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee More articles by this author Paula Hurley Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee More articles by this author Expand All Advertisement Loading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.